Get startedLog in
    Picture of Atea Pharmaceuticals logo

    AVIR — Atea Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapNeutral
    All News

    Brief: Bradley L. Radoff And Michael Torok Calls For Atea Pharmaceuticals To Appoint New, Lead Independent Director To Oversee Strategic Review Process

    Picture of Atea Pharmaceuticals logoAtea Pharmaceuticals
    18/12/2024 22:32
    Dec 18 (Reuters) - 
  
    * BRADLEY L. RADOFF AND MICHAEL TOROK: CALLS FOR ATEA
PHARMACEUTICALS TO APPOINT NEW, LEAD INDEPENDENT DIRECTOR TO
OVERSEE STRATEGIC REVIEW PROCESS
    * BRADLEY L. RADOFF AND MICHAEL TOROK: COLLECTIVELY OWN
ABOUT 3%
OF OUTSTANDING SHARES OF ATEA PHARMACEUTICALS

Source text:  ID:nBw2QXJ4ha 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Atea Pharmaceuticals

    See all news